Search details
1.
BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children.
J Clin Immunol
; 43(3): 557-567, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36383294
2.
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.
J Allergy Clin Immunol
; 149(2): 488-516.e9, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34848210
3.
Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
J Infect Dis
; 226(8): 1407-1411, 2022 10 17.
Article
in English
| MEDLINE | ID: mdl-35759252
4.
Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.
N Engl J Med
; 380(21): 2009-2019, 2019 05 23.
Article
in English
| MEDLINE | ID: mdl-31112384
5.
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.
J Allergy Clin Immunol
; 147(5): 1594-1601, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33667479
6.
Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations.
N Engl J Med
; 378(10): 891-901, 2018 Mar 08.
Article
in English
| MEDLINE | ID: mdl-29504498
7.
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations.
J Biopharm Stat
; 30(6): 1026-1037, 2020 11 01.
Article
in English
| MEDLINE | ID: mdl-32941098
8.
Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma.
N Engl J Med
; 375(7): 619-30, 2016 Aug 18.
Article
in English
| MEDLINE | ID: mdl-27532828
9.
Evaluation of salivary alpha-amylase as a potential biomarker of inhaled ß2-agonist response.
Ann Allergy Asthma Immunol
; 130(5): 664-665, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36738784
10.
Race is associated with differences in airway inflammation in patients with asthma.
J Allergy Clin Immunol
; 140(1): 257-265.e11, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28069248
11.
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
J Clin Immunol
; 37(3): 301-310, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28316003
12.
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study.
J Clin Immunol
; 37(6): 603-612, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28755067
13.
Individualized therapy for persistent asthma in young children.
J Allergy Clin Immunol
; 138(6): 1608-1618.e12, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27777180
14.
Running a virtual allergy division and training program in the time of COVID-19 pandemic.
J Allergy Clin Immunol
; 145(5): 1357-1359, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32243877
15.
Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation?
J Allergy Clin Immunol
; 142(1): 308-311.e9, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29518418
16.
Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Front Immunol
; 15: 1348041, 2024.
Article
in English
| MEDLINE | ID: mdl-38318183
17.
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
mBio
; 14(1): e0339322, 2023 02 28.
Article
in English
| MEDLINE | ID: mdl-36728420
18.
Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infection.
Front Med (Lausanne)
; 10: 1227883, 2023.
Article
in English
| MEDLINE | ID: mdl-37908849
19.
Evaluation of the Panbio™ COVID-19 IgG rapid test device performance.
Heliyon
; 9(12): e22612, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38125420
20.
Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
J Clin Immunol
; 37(6): 613, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28714047